peripheral arterial disease phenotype
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| CHRNA5 | risk_factor_for | peripheral arterial disease | — | 1 |
| CHRNA5 | associated_with | peripheral arterial disease | — | 1 |
| warfarin | associated_with | peripheral arterial disease | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations. (2022)
- Human Genetics of Addiction: New Insights and Future Directions. (2018)
- G = E: What GWAS Can Tell Us about the Environment. (2016)
- Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. (2011)
- Special article: gait measures indicate underlying focal gray matter atrophy in the brain of older adults. (2008)
- One SNP linked to two diseases-addiction and cancer: a double whammy? Nicotine addiction and lung cancer susceptibility. (2008)
- C-reactive protein: a critical update. (2003)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| peripheral arterial disease | phenotype | 7 | 8 |